Home
Name
ABT-510
Alternate Names
None
Abbreviations
None
Category
Chemotherapy
Subcategory
Cytostatic agent--antiangiogenic agent
NSC Number
None
Primary Site
Liver
other cancer
Histology
None
Remarks
As of March 2015, this drug has not received FDA approval and numerous clinical trials did not demonstrate definite clinical efficacy.
Coding
This drug should be coded
